Literature DB >> 11144991

The process of knowledge discovery from large pharmacokinetic data sets.

E I Ette1, P Williams, E Fadiran, F O Ajayi, L C Onyiah.   

Abstract

The advent of statistical software with powerful graphical and modeling capabilities has revolutionized the manner in which pharmacokinetic and pharmacodynamic analyses are performed. Knowledge discovery from a large (population) pharmacokinetic data set incorporates all steps taken from data assembly to the development of a population pharmacokinetic model and the communication of the results thereof. The process can be formalized into a number of steps: (1) creation of a data set for pharmacokinetic knowledge discovery, (2) data quality analysis, (3) data structure analysis (exploratory examination of raw data), (4) determination of the basic pharmacokinetic model that best describes the data and generating post hoc empiric individual Bayesian parameter estimates, (5) the search for patterns and relationships between parameters and parameters and covariates by visualization, (6) the use of modern statistical modeling techniques for data structure revelation and covariate selection, (7) consolidation of the discovered knowledge into irreducible form (i.e., developing a population pharmacokinetic model), (8) the determination of model robustness (determination of the reliability of model parameter estimates), and (9) the communication and integration of the discovered pharmacokinetic knowledge. This process is discussed, and a motivating example is presented. The use of modern graphical, modeling, and statistical techniques for knowledge discovery from large pharmacokinetic data sets has given the data analyst the freedom to choose statistical methodology appropriate to the problem at hand with the maximization of information extraction, rather than on the basis of mathematical/statistical tractability.

Mesh:

Year:  2001        PMID: 11144991     DOI: 10.1177/00912700122009809

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  5 in total

1.  Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.

Authors:  Ene I Ette; Leonard C Onyiah
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jul-Sep       Impact factor: 2.441

2.  Data supplementation: a pharmacokinetic/pharmacodynamic knowledge creation approach for characterizing an unexplored region of the response surface.

Authors:  Ene I Ette; Hui-May Chu; Christopher J Godfrey
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

Review 3.  Population pharmacokinetic studies in pediatrics: issues in design and analysis.

Authors:  Bernd Meibohm; Stephanie Läer; John C Panetta; Jeffrey S Barrett
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

4.  PKreport: report generation for checking population pharmacokinetic model assumptions.

Authors:  Xiaoyong Sun; Jun Li
Journal:  BMC Med Inform Decis Mak       Date:  2011-05-16       Impact factor: 2.796

5.  Exploring population pharmacokinetic modeling with resampling visualization.

Authors:  Fenghua Zuo; Jun Li; Xiaoyong Sun
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.